Drugs recalls due to toxicity not only have a huge effect on the cost of developing new therapeutics but it also leads to many years of wasted research. That is why it is vital to get things right from the outset with more precise testing of new leads using more accurate in-vitro models. High Throughput Screening using biochemical assays has been a mainstay of the pharmaceutical industry in the past, but with the cost of developing a single lead reaching exorbitant amounts, it is now necessary to look at more cost-efficient methods that more accurately represent the in-vivo environment.
Contact Show Management for Exact Location
Presidents, Chief Executives, Chief Scientific Officers, Chief Operating Officers, Senior Vice Presidents, Vice Presidents, Heads, Senior Directors, Directors, Clinicians, Principal Scientists, Principal Investigators, Managers, Project/Team Leaders in: Bioanalytical Development, High-Throughput/High-Content Screening Operations, Compound Profiling, Drug Discovery/Validation, ADMET, Pre-clinical Development, Medicinal Chemistry, Chemistry and Bioapplications, Pharmacokinetics/Pharmacodynamics, Investment and Venture Capital.
Contact Show Management for Exact Venue.